Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Rosuvastatin calcium tablet and preparation process thereof

A technology of rosuvastatin calcium and its preparation process, which is applied in the field of rosuvastatin calcium tablets and its preparation process, can solve the problems of difficult control of product impurities, impact on product quality, high production cost, etc., so as to facilitate popularization and reduce production cost , The effect of improving productivity

Pending Publication Date: 2020-08-18
ABA CHEM CORP
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Aiming at the deficiencies of the prior art, the present invention provides a rosuvastatin calcium tablet and its preparation process, which has the advantages of simple and efficient production, etc., and solves the problems of high production cost, long cycle and product containing Impurities are not easy to control, leading to problems such as affecting product quality

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Embodiment one: a kind of rosuvastatin calcium tablet, comprise following raw material: [4-[4-fluorophenyl-6-(1-methylethyl)-2-[N-methyl-(N-methyl Sulfonyl)amino]]-5-pyrimidinyl]methyltriphenylphosphine bromide, (4R-cis)-6-formyl-2,2-dimethyl-1,3-dioxane-4 - cyclopentyl acetate, potassium carbonate, dimethyl sulfoxide, toluene, acetonitrile, ethyl acetate, methanol, isopropanol, sodium hydroxide, sodium chloride and calcium chloride.

[0018] Another technical problem to be solved by the present invention is to provide a preparation process of rosuvastatin calcium tablets, comprising the following steps:

[0019] 1) Add 67.8g (0.1mol) [4-[4-fluorophenyl-6-(1-methylethyl)-2-[N-methyl-(N-methylsulfonyl) to the first reaction flask )amino]]-5-pyrimidinyl]methyltriphenylphosphine bromide, 27.0g (0.1mol)(4R-cis)-6-formyl-2,2-dimethyl-1,3-diox Hexyl-4-cyclopentyl acetate, 300mL dimethyl sulfoxide, stirred and dissolved at room temperature; and heated to 25-45 degrees Celsiu...

Embodiment 2

[0023] Embodiment two: a kind of rosuvastatin calcium tablet, comprise following raw material: [4-[4-fluorophenyl-6-(1-methylethyl)-2-[N-methyl-(N-methyl Sulfonyl)amino]]-5-pyrimidinyl]methyltriphenylphosphine bromide, (4R-cis)-6-formyl-2,2-dimethyl-1,3-dioxane-4 - cyclopentyl acetate, potassium carbonate, dimethyl sulfoxide, toluene, acetonitrile, ethyl acetate, methanol, isopropanol, sodium hydroxide, sodium chloride and calcium chloride.

[0024] Another technical problem to be solved by the present invention is to provide a preparation process of rosuvastatin calcium tablets, comprising the following steps:

[0025]1) Add 67.8g (0.1mol) [4-[4-fluorophenyl-6-(1-methylethyl)-2-[N-methyl-(N-methylsulfonyl) to the first reaction flask )amino]]-5-pyrimidinyl]methyltriphenylphosphine bromide, 27.0g (0.1mol)(4R-cis)-6-formyl-2,2-dimethyl-1,3-diox Hexyl-4-cyclopentyl acetate, 300mL dimethyl sulfoxide, stirred and dissolved at room temperature; and heated to 45-75 degrees Celsius...

Embodiment 3

[0029] Embodiment three: a kind of rosuvastatin calcium tablet, comprise following raw material: [4-[4-fluorophenyl-6-(1-methylethyl)-2-[N-methyl-(N-methyl Sulfonyl)amino]]-5-pyrimidinyl]methyltriphenylphosphine bromide, (4R-cis)-6-formyl-2,2-dimethyl-1,3-dioxane-4 - cyclopentyl acetate, potassium carbonate, dimethyl sulfoxide, toluene, acetonitrile, ethyl acetate, methanol, isopropanol, sodium hydroxide, sodium chloride and calcium chloride.

[0030] Another technical problem to be solved by the present invention is to provide a preparation process of rosuvastatin calcium tablets, comprising the following steps:

[0031] 1) Add 67.8g (0.1mol) [4-[4-fluorophenyl-6-(1-methylethyl)-2-[N-methyl-(N-methylsulfonyl) to the first reaction flask )amino]]-5-pyrimidinyl]methyltriphenylphosphine bromide, 27.0g (0.1mol)(4R-cis)-6-formyl-2,2-dimethyl-1,3-diox Hexyl-4-cyclopentyl acetate, 300mL dimethyl sulfoxide, stirred and dissolved at room temperature; and heated to 75-120 degrees Cel...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of pharmaceutical preparations and discloses a rosuvastatin calcium tablet. [4-[4-fluorophenyl-6-(1-methylethyl)-2-[N_ methyl-(N-methylsulfonyl) amino]-5-pyrimidyl] methyltriphenylphosphonium bromide, (4R-cis)-6-formyl-2, 2-dimethyl-1, 3-dioxane-4-cyclopentyl acetate, potassium carbonate, dimethyl sulfoxide, methylbenzene, acetonitrile, ethyl acetate, methanol, isopropanol, sodium hydroxide, sodium chloride and calcium chloride. According to the rosuvastatin calcium tablet and the preparation process thereof, a plurality of experiments prove that: when reaction temperature is about 75 DEG C in intermediate synthesis, alkali is the optimal experimental condition of the potassium carbonate, and reaction raw materials can react completely, the generation of multiple impurities is prevented, productivity can be improved, and production cost is reduced; a hydrochloric acid solution is added in a rosuvastatin cyclopentyl ester synthesis process toneutralize redundant acid and alkali, so that the generation of the impurities is further reduced; and therefore, high-purity production is achieved.

Description

technical field [0001] The invention relates to the technical field of pharmaceutical preparations, in particular to a rosuvastatin calcium tablet and a preparation process thereof. Background technique [0002] Rosuvastatin Caleium (RosuVastatin Caleium), chemical name: bis-[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl) Amino]-pyrimidin-5-yl](3R,5S)-3,5-hydroxyhept-6-enoic acid] calcium salt (2:1), rosuvastatin calcium is suitable for diet control and other non-drug treatments Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia) or mixed dyslipidemia (type IIb) whose dyslipidemia cannot be adequately controlled (eg, exercise therapy, weight loss) is also suitable In patients with homozygous familial hypercholesterolemia, as an adjunct to diet control and other lipid-lowering measures (such as LDL depletion therapy), or when these methods are not applicable. [0003] Traditional rosuvastatin calcium production cost...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D239/42A61K9/20A61K31/505A61P3/06
CPCC07D239/42A61K9/2095A61K31/505A61P3/06
Inventor 徐军蒋信义张敏华周宇
Owner ABA CHEM CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products